Does Alzheimer's disease start early in life?

Molecular Psychiatry

Volumn 2, Issue 1, 1997, Pages 21-25

  Ohm, T G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Aging; Alzheimer's disease; Development; Stages; Therapy

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN E2; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; CAUSE OF DEATH; DISEASE COURSE; EARLY DIAGNOSIS; GENE MUTATION; HUMAN; LANGUAGE ABILITY; MYDRIASIS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030946268     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000231     Document Type: Short Survey

References (23)

1. Ohm TG, Müller H, Braak H, Bohl J. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofihrillary changes. Neuroscience 1995; 64: 209-217.
2. Snowdon DA, Kemper SJ, Mortimer JA, Greiner LH, Wekstein DR, Markesbery WR. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. JAMA 1996; 275: 528-532.
3. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994; 17: 525-530.
4. Poirier J, Hess M, May PC, Finch CE. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 1991; 77: 97110.
5. Nathan BP, Bellosta S, Sanan DA, Weisgrabor KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 2G4: 850-852.
6. Vandermeeren M, Mercken M, Vanmechelen E, Six J, vande-Voorde A, Martin JJ, Cras P. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem 1993; 61: 1828-1834.
7. Marx JL. Detecting Alzheimer's disease. Science 1995; 267: 1577.
8. Huang HM, Gibbson G. Altered beta-adrenergic receptorstimulated cAMP formation in cultured skin fibroblasts from Alzheimer donors. J Biol Chem 1993; 268: 1461614621.
9. Van Huynh T, Cole G, Katzman R, Huang KP, Saitoh T. Reduced protein kinase C immunoreactivity and altered protein phosphorylation in Alzheimer's disease fibroblasts. Arch Neural 1989; 46: 1195-1199.
10. Piletz JE, Sarasua M, Whitehouse P, Chotani M. Intracellular membranes are more fluid in platelets of Alzheimer's disease patients. Neurobiol Aging 1991; 12: 401-406.
11. Zubenko GS, Cohen BM, Boiler F, Malinkowa I, Keefe N, Chojnacki B. Platelet membrane abnormality in Alzheimer's disease. Ann Neural 1987; 22: 237-244.
12. Hicks N, Brammer MJ, Hymas N, Levy R. Platelet membrane properties in Alzheimer and multi-infact dementias. Ah Dis Rel Dis 1987; 1: 90-97.
13. Ohgami T, Kitamoto T, Tateishi J. Alzheimer's amloid precursor protein mRNA without exon 15 is ubiquitously expressed except in the rat central nervous system. Brain Res Mol Brain Res 1993; 20: 240-244.
14. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Proc Natl Acad Sci USA 1995; 92: 47254727.
15. Ohm TG, Kirea M, Bohl J, Scharnagl H, Groß W, März W. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995; GO: 583587.
16. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell Jr PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, Tanzi RE, Gusella JF, Small GW, Roses AD, Pericak-Vance MA, Haines JL. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995; 45: 1323-1328.
17. Rebeck WG, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11: 575580.
18. Ohm TG, Scharnagl H, März W. Apolipoprotein E and neurofibrillary tangles in Alzheimer's disease. Proc CINP Regional Conference. Bibliotheca Psychiatrica 1996; 167: (in press).
19. Huang DY, Weisgraber KH, Goedert M, Saunders AM, Roses AD, Strittmatter WJ. ApoE3 binding to tau tandem repeat I is abolished by serine262 phosphorylation. Neurosci Lett 1995; 192: 109-112.
20. Leverenz J, Bird T, Nochlin D, Greonberg SG, Saper CB. Unique tau and neurofibrillary tangle distribution in the hippocampal formation of patients with familial 'tangle only' dementia. Soc Neurosci Abstr 1992; 18: 562.
21. Bancher C, Jellinger KA. Neurofibrillary tangle predominant form of senile dementia of Alzheimer typo: a rare subtype in very old subjects. Acta Neuropathol Berlin 1994; 83: 565-570.
22. Bancher C, Braak H, Fischer P, Jellinger KA. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993; 162: 179-182.
23. Ohm TG, Scharnagl H, März W, Bohl J. ApoE-isoforms and the development of pre-clinical phases of Alzheimer's disease. Ann Neural 1996; (submitted).